| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/15/2001 | CN1307891A Chinses medicine for treating cataract, glaucoma and nasosinusitis and its preparation |
| 08/15/2001 | CN1307887A Medicine composite and its preparation |
| 08/15/2001 | CN1307881A Medicine for treating cough and asthma |
| 08/15/2001 | CN1307877A Plaster for cold |
| 08/15/2001 | CN1069535C Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274578 sPLA2 inhibitor ester |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057044A1 Pyridoxazine derivatives |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001056581A1 Powdered preparation for inhalation and powder inhalant containing the same packed |
| 08/09/2001 | WO2001056574A1 Use of desloratadine for treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056571A1 Treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001019342A3 Pharmaceutical formulation of fluticasone propionate |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000066094A3 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
| 08/09/2001 | WO2000055072A3 Aerosol metering valve |
| 08/09/2001 | WO2000047554A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2000005224A3 Heterocyclic derivatives and their use as integrin inhibitor |
| 08/09/2001 | US20010012896 Crystallization, heating |
| 08/09/2001 | US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012845 Adminstering an E-type prostaglandin ligand and a cyclooxygenase-2 enzyme selective inhibitor compound in combination with a carrier to treat inflammation |
| 08/09/2001 | US20010012837 Anti-ulcer composition |
| 08/09/2001 | US20010012834 Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399214A1 Novel heterocyclic amide derivatives |
| 08/09/2001 | CA2399022A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398261A1 Treating allergic and inflammatory conditions |
| 08/08/2001 | EP1122243A1 Novel imidazoles with anti-inflammatory activity |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121372A1 Adenine derivatives |
| 08/08/2001 | EP1121360A1 Il-8 receptor antagonists |
| 08/08/2001 | EP1121359A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 08/08/2001 | EP1121353A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 08/08/2001 | EP1121123A2 Formulations of fexofenadine |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307575A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307560A Amidino and guanidino beta-azetidinone tryptase inhibitors |
| 08/08/2001 | CN1307559A Substituted beta-diketones and their use |
| 08/08/2001 | CN1307470A Pharmaceutical formulations for aerosols with two or more active substances |
| 08/08/2001 | CN1306964A Method for separating active part of caterpillar fungus, and medical use thereof |
| 08/08/2001 | CN1306840A Chinese medicine for treating acute and chronic rhinitis and nasosinusitis |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069206C External-use powder for treatment of tracheitis and asthma |
| 08/08/2001 | CN1069200C Medicine made from plum and apricot and production method thereof |
| 08/08/2001 | CN1069192C Aerosol preparation and preparation method thereof |
| 08/08/2001 | CN1069191C Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 08/07/2001 | US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs |
| 08/07/2001 | US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy |
| 08/07/2001 | US6271206 Stabilization; drug delivery |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | CA2121199C Ether derivatives |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055217A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | WO2001055214A2 Asthma-associated gene |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055149A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055094A1 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2001054685A1 Mucin synthesis inhibitors |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |